Research on a universal vaccine for influenza
NIAID Centers of Excellence for Influenza Research and Response (CEIRR): Universal Influenza Vaccine Research Activities
['FUNDING_OTHER'] · EMORY UNIVERSITY · NIH-11259413
This study is looking at how the flu virus spreads and how our bodies fight it, by gathering information from both people and animals, to help create a better flu vaccine that could protect everyone.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | EMORY UNIVERSITY (nih funded) |
| Locations | 1 site (ATLANTA, UNITED STATES) |
| Trial ID | NIH-11259413 on ClinicalTrials.gov |
What this research studies
This research investigates the factors that affect the evolution and transmission of influenza viruses, as well as the immune response to these infections. It involves cohort studies and sampling from both humans and animals to better understand how influenza spreads and how effective vaccinations can be developed. The goal is to identify the immune correlates that provide protection against the flu, which could lead to the development of a universal influenza vaccine.
Who could benefit from this research
Good fit: Ideal candidates for participation include individuals who are at risk of influenza infection, such as those with compromised immune systems or chronic health conditions.
Not a fit: Patients who are not at risk for influenza or those who have already received effective vaccinations may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of a universal influenza vaccine that provides broader and longer-lasting protection against various strains of the virus.
How similar studies have performed: Previous research has shown promise in understanding immune responses to influenza, but the development of a universal vaccine remains a novel and challenging goal.
Where this research is happening
ATLANTA, UNITED STATES
- EMORY UNIVERSITY — ATLANTA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: LOWEN, ANICE — EMORY UNIVERSITY
- Study coordinator: LOWEN, ANICE
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Disease Outcome, flu infection